Driving Medical Affairs Impact & Business Case Strategies

STUDY OVERVIEW
BENCHMARK CLASS
SPECIAL OFFER

Non-members: Click here to review a complimentary excerpt from “Assessing the Impact of Medical Affairs: Driving Impact and Making the Business Case”

STUDY OVERVIEW

In today’s value-driven landscape, Medical Affairs teams are under constant pressure to demonstrate their impact to senior leadership and external stakeholders. Transitioning from traditional execution-based metrics to outcomes-based measures is crucial for aligning activities with business success and securing necessary resources. This shift enables Medical Affairs leaders to connect their contributions to real-world results, thereby strengthening their value story and overall impact.

Best Practices LLC conducted this benchmarking research to uncover the strategies Medical Affairs groups are using to drive significant impact and make a compelling business case. This study provides detailed findings and industry benchmarks on driving medical impact, overcoming measurement hurdles, securing commercial co-funding, and articulating Medical Affairs' value. Utilize these insights to elevate your value story, overcome challenges, and ensure your contributions are recognized and supported.

KEY TOPICS

Driving Medical Impact
Impact Measurement Hurdles
Commercial Co-funding
Making the Case for Medical Affairs Value
Key Success Factors for High Medical Impact

KEY METRICS

Impact of Medical Affairs in fulfilling the organizational mission
Medical Affairs’ success in producing measurable impact on external stakeholder objectives
Top barriers in Medical Affairs organization’s ability to measure external impact and tell a compelling value story
Commercial’s resource allocation for co-funding impactful Medical programs
Rating of supporting capabilities that drive Medical Affairs impact

SAMPLE KEY FINDINGS

Impact Measurement Hurdles: Resource limitations (such as access to funding and data) are the biggest impediments to impact measurement.

METHODOLOGY

This Best Practices, LLC study engaged 34 Medical Affairs leaders who are improving Medical impact across 23 top biopharma organizations through a benchmarking survey. Deep-dive interviews were also conducted with participating Medical Affairs leaders to capture additional insights and nuances of impact.

Industries Profiled:
Pharmaceutical; Biopharmaceutical; Biotech; Manufacturing; Health Care; Medical Device; Consumer Products; Clinical Research; Laboratories

Companies Profiled:
AbbVie; Alkermes; Astellas; AstraZeneca; Axsome Therapeutics; Biogen; BioMarin; Boehringer Ingelheim; Daiichi Sankyo; Eisai; Gilead Sciences; Jazz Pharmaceuticals; Johnson & Johnson; Novartis; Novo Nordisk; PDS Biotechnology; Pfizer; Regeneron; Sanofi; scPharmaceuticals; Takeda Pharmaceuticals; Vertex Pharmaceuticals; Viatris

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.

Assessing the Impact of Medical Affairs: Driving Impact and Making the Business Case

ID: 5816

Features:

Pages/Slides: 23

Published: 2024

Delivery Format: Online PDF Document

RELATED RESEARCH

1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6D228E4F5C4162DF800258B7200414F57
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-assessing-impact-of-medical-affairs-driving-impact-making-business-case?opendocument
18
19opendocument
203.238.82.77
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB